Cargando…

Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients

There are limited data of amikacin pharmacokinetics (PK) in the elderly population. Hence, we aimed to describe the population PK of amikacin in elderly patients (>70 years old) and to establish optimized initial dosing regimens. We simulated individual maximum concentrations in plasma (Cmax) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Hideo, Parker, Suzanne L., Roberts, Jason A., Hagihara, Mao, Asai, Nobuhiro, Yamagishi, Yuka, Paterson, David L., Mikamo, Hiroshige
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909551/ https://www.ncbi.nlm.nih.gov/pubmed/33498481 http://dx.doi.org/10.3390/antibiotics10020100

Ejemplares similares

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017)

A Systematic Review and Meta-Analysis of Efficacy and Safety of Azithromycin Versus Moxifloxacin for the Initial Treatment of Mycoplasma genitalium Infection
por: Kato, Hideo, et al.
Publicado: (2022)

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Kato, Hideo, et al.
Publicado: (2022)

A Large Gap in Patients’ Characteristics and Outcomes between the Real-World and Clinical Trial Settings in Community-Acquired Pneumonia and Healthcare-Associated Pneumonia
por: Asai, Nobuhiro, et al.
Publicado: (2022)

Comparison of microbial detection rates in microbial culture methods versus next-generation sequencing in patients with prosthetic joint infection: a systematic review and meta-analysis
por: Kato, Hideo, et al.
Publicado: (2023)

A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
por: Kato, Hideo, et al.
Publicado: (2022)

Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis
por: Kato, Hideo, et al.
Publicado: (2022)

A severe case of Streptococcal pyogenes empyema following influenza A infection
por: Asai, Nobuhiro, et al.
Publicado: (2019)

Secondary organizing pneumonia following viral pneumonia caused by severe influenza B: a case report and literature reviews
por: Asai, Nobuhiro, et al.
Publicado: (2017)

Clinical manifestations and radiological features by chest computed tomographic findings of a novel coronavirus disease-19 pneumonia among 92 patients in Japan
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Efficacy of Combination Therapies for the Treatment of Multi-Drug Resistant Gram-Negative Bacterial Infections Based on Meta-Analyses
por: Umemura, Takumi, et al.
Publicado: (2022)

Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia
por: Kato, Hideo, et al.
Publicado: (2022)

A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone
por: Hirai, Jun, et al.
Publicado: (2023)

Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature
por: Asai, Nobuhiro, et al.
Publicado: (2019)

Combination of Sequential Organ Failure Assessment (SOFA) score and Charlson Comorbidity Index (CCI) could predict the severity and prognosis of candidemia more accurately than the Acute Physiology, Age, Chronic Health Evaluation II (APACHE II) score
por: Asai, Nobuhiro, et al.
Publicado: (2021)

The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy
por: Asai, Nobuhiro, et al.
Publicado: (2022)

Brevibacterium paucivorans bacteremia: case report and review of the literature
por: Asai, Nobuhiro, et al.
Publicado: (2019)

Can presepsin uniformly respond to various pathogens? - an in vitro assay of new sepsis marker -
por: Koizumi, Yusuke, et al.
Publicado: (2020)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing Enterobacter cloacae and Klebsiella pneumoniae in Murine Pneumonia Model
por: Hagihara, Mao, et al.
Publicado: (2021)

Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report
por: Hagihara, Mao, et al.
Publicado: (2015)

Comparative Effectiveness of Ampicillin/Sulbactam versus Cefazolin as Targeted Therapy for Bacteremia Caused by Beta-Lactamase-Producing Methicillin-Sensitive Staphylococcus aureus: A Single-Center Retrospective Study
por: Hirai, Jun, et al.
Publicado: (2022)

A Gap of Patients with Infective Endocarditis between Clinical Trials and the Real World
por: Asai, Nobuhiro, et al.
Publicado: (2023)

Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan
por: Hirai, Jun, et al.
Publicado: (2023)

474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting
por: Hirai, Jun, et al.
Publicado: (2023)

A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid
por: Shibata, Yuichi, et al.
Publicado: (2023)

Intra-Abdominal Abscess and Bacteremia Due to Stenotrophomonas maltophilia After Total Gastrectomy: A Case Report and Literature Review
por: Hirai, Jun, et al.
Publicado: (2023)

COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?()
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Comparative study of SmartAmp assay and reverse transcription-polymerase chain reaction by saliva specimen for the diagnosing COVID-19
por: Asai, Nobuhiro, et al.
Publicado: (2022)

Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19
por: Asai, Nobuhiro, et al.
Publicado: (2021)

The First Case Report of Community-Acquired Infective Endocarditis Due to Sequence Type 1223 Staphylococcus argenteus Complicated with Convexity Subarachnoid Hemorrhage
por: Hirai, Jun, et al.
Publicado: (2022)

The Prophylactic Effect of Anti-influenza Agents for an Influenza Outbreak in a University Hospital
por: Hagihara, Mao, et al.
Publicado: (2018)

Clostridium butyricum MIYAIRI 588-Induced Protectin D1 Has an Anti-inflammatory Effect on Antibiotic-Induced Intestinal Disorder
por: Ariyoshi, Tadashi, et al.
Publicado: (2020)

Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation
por: Hagihara, Mao, et al.
Publicado: (2021)

Lemierre Syndrome Due to Dialister pneumosintes: A Case Report
por: Hirai, Jun, et al.
Publicado: (2022)

Three Successfully Treated Cases of Lodderomyces elongisporus Fungemia: Case Reports and a Review of the Literature
por: Asai, Nobuhiro, et al.
Publicado: (2023)

Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host
por: Ariyoshi, Tadashi, et al.
Publicado: (2021)

Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care
por: Mikamo, Hiroshige, et al.
Publicado: (2022)

Necrotizing pneumonia due to Pseudomonas aeruginosa secondary to severe COVID‐19 pneumonia
por: Hirai, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lm49r4nedddmroqq5c429r9pbv